Nick Wall

Nick joined the Orbis team in August 2016.

Nick’s corporate finance experience has seen him involved in a number of transactions across a variety of sectors, in addition to valuation and due diligence project based work.

Prior to joining Orbis, Nick studied Mathematics at the University of Bristol before joining UBS Wealth Management in Research/ Business Development.

Whilst at Orbis, Nick completed his CISI Diploma in Corporate Finance in 2018.

Contact Nick

Recent News

Orbis advise on the sale of Little BigPaw to Petbuddy Group AB
23rd September 2022

Orbis have advised the shareholders of The First Class Pet Company (trading as Little BigPaw) on the sale of the business to Petbuddy Group AB, an investor backed group focussed on acquiring and growing premium pet brands.

Orbis advise on the sale of Regis Healthcare to Elysium Healthcare
14th September 2022

Orbis advised on the sale of Regis Healthcare, a CAMHS low secure mental health hospital, to Elysium Healthcare.

Orbis advise Stuart Turner on their acquisition of AGM
25th August 2022

Orbis has advised Stuart Turner on their strategic acquisition of Aquatronic Group Management (“AGM”), a leading provider of cold-water boosting equipment and services in the UK.

Orbis advise on the sale of OGL Computer Support and CyberGuard Technologies to Wavenet
18th August 2022

Orbis Partners have advised on the sale of OGL Computer Support and CyberGuard Technologies to Wavenet.

Registered in England No.9098428 Registered Office: One Eleven, Edmund St, Birmingham B3 2HJ
The statutory directors of Orbis Partners Ltd are Chris Gregory, James Grenfell, Gary Ecob and Shah Zaki.